Hobby Lobby vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
World's largest privately held arts-and-crafts retailer with 1,072 stores targeting 1,500 US stores by 2026; $7.9B revenue in 2023; Oklahoma City-based; 100% family-owned with faith-based Sunday closure policy;
About
Hobby Lobby is the world's largest privately held arts-and-crafts retailer, founded in 1972 by David Green in Oklahoma City, Oklahoma. What started as a 300-square-foot picture frame shop in the Green family garage has grown into a national retail institution with a distinct identity rooted in Christian values. The company is 100% family-owned and famously closed on Sundays, a policy reflecting its faith-based operating philosophy.\n\nHobby Lobby's stores average 55,000 square feet and carry more than 80,000 products across crafts, fabric, floral, seasonal décor, frames, and art supplies. The company operates its own manufacturing and sourcing operations across Asia, contributing to its ability to offer deep, frequent discounts — typically 40% off on rotating categories. Hobby Lobby serves DIY enthusiasts, home decorators, teachers, and small craft business owners primarily in suburban and rural US markets. Its everyday low-price strategy and massive store format make it a destination retailer.\n\nHobby Lobby operates 1,072 stores across the United States and generated $7.9 billion in revenue in 2023. The company has an ambitious expansion plan targeting 1,500 US stores by 2026, representing nearly 40% growth from its current footprint. Despite competition from Amazon, Michaels, and JOANN, Hobby Lobby has maintained strong performance through its differentiated product mix, consistent promotional cadence, and loyal customer base among religious and craft communities.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.